Lead, cadmium, and selenium in the blood of patients with sporadic amyotrophic lateral sclerosis

Italian Journal of Neurological Sciences

Volumn 18, Issue 2, 1997, Pages 87-92

  Vinceti, M ^a   Guidetti, D ^b   Bergomi, M ^c   Caselgrandi, E ^b   Vivoli, R ^a   Olmi, M ^b   Rinaldi, L ^a   Rovesti, S ^c   Solime F ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

^c Servizio di Medicina Del Lavoro di Scandiano   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Blood; Cadmium; Case control study; Epidemiology; Lead; Motor neuron disease; Selenium; Serum; Smoking; Trauma

Indexed keywords

CADMIUM; LEAD; SELENIUM;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; RISK FACTOR;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; CADMIUM; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEAD; MALE; MIDDLE AGED; RISK FACTORS; SELENIUM;

EID: 0031111378     PISSN: 03920461     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01999568     Document Type: Article

References (37)

1. ARMON C, KURLAND LT, DAUBE JR, O'BRIEN PC. Epidemiologie correlates of sporadic amyotrophic lateral sclerosis. Neurology 1991; 41: 1077-1084.
2. ARVIDSON B. Retrograde axonal transport of cadmium in the rat hypoglossal nerve. Neurosci Lett 1985; 62: 45-49.
3. BERGOMI M, BORELLA P, FANTUZZI G. et al. Relationship between lead exposure indicators and neuropsychological performance in children. Dev Med Child Neurol 1989; 31: 181-190.
4. BRESLOW NE, DAY NE, HALVORSEN KT, PRENTICE RL, SABAI C. Estimation of multiple relative risk functions in matched case-control studies. Am J Epidemiol 1978; 108: 299-307.
5. CHANCELLOR AM, WARLOW CP. Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. J Neurol Neurosurg Psychiatry 1992; 55: 1106-1115.
6. ENVIRONMENTAL HEALTH CRITERIA 134: Cadmium. Geneva: World Health Organization, 1992.
7. FELMUS MT, PATTEN BM, SWANKE L. Antecedent events in amyotrophic lateral sclerosis. Neurology 1976; 26: 167-172.
8. FITZMAURICE PS, SHAW 1C, KLEINER HE. et al. Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle Nerve 1996; 19: 797-798.
9. GRANIERI E, CARRERAS M, TOLA R. et al. Motor neuron disease in the province of Ferrara, Italy, in 1964-1982. Neurology 1988; 38: 1604-1608.
10. GUIDETTI D, BONDAVALLI M, SABADINI R. et al. Epidemiological survey of amyotrophic lateral sclerosis in the Province of Reggio Emilia, Italy. Influence of environmental exposure to lead. Neuroepidemiology 1996; 15: 301-312.
11. GUNNARSSON L, BODIN L, SÖDERFELDT B, AXELSON O. A case-control study of motor neurone disease: its relation to heritability, and occupational exposures, particularly to solvents. Br J Ind Med 1992; 49: 791-798.
12. HILLEL AD, MILLER RM, YORKSTON K, MCüONALD E, NORRIS FH, KONIKOW N. Amyotrophic lateral sclerosis severity scale. Neuroepidemiology 1989; 8: 142-150.
13. INCE PG, SHAW PJ, CANDY JM, et al. Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease. Neurosci Lett 1994; 182: 87-90.
14. KAHANA E, ZILBER N. Changes in the incidence of amyotrophic lateral sclerosis in Israel. Ann Neurol 1984; 41: 157-160.
15. KILNESS AW, HOCHBERG FH. Amyotrophic lateral sclerosis in a high selenium environment. JAMA 1977; 237: 2843-2844.
16. KRAMER GF, AMES BN. Mechanisms of mutagenicity and toxicity of sodium selenite (Na2SeO3) in Salmonella typhimurium. Mutât Res 1988; 201: 169-180.
17. KURLAND LT, RADHAKRISHAN K, SMITH GE, ARMON C, NEMETZ PN. Mechanical trauma as a risk factor in classic amyotrophic lateral sclerosis: lack of epidemiologic evidence. J Neurol Sei 1992; 113: 133-143.
18. KURLANDER HM, PATTEN BM. Metals in spinal cord tissue of patients dying of motor neuron disease. Ann Neurol 1979; 6: 21-24.
19. KURTZKE JF. Risk factors in amyotrophic lateral sclerosis. Adv Neurol 1991; 56: 245-270.
20. LOUWERSE ES, BUCHET J, VAN DIJK MA, DE JONG JMBV, LAUWERYS RR. Urinary excretion of lead and mercury after oral administration of meso-2,3-dimercaptosuccinic acid in patients with motor neurone disease. Int Arch Occup Environ Health 1995; 67: 135-138.
21. MITCHELL JD. Heavy metals and trace elements in amyotrophic lateral sclerosis. Neurol Clin 1987; 5: 43-60.
22. MITCHELL JD, EAST BW, HARRIS IA, PENTLAND B. Manganese, selenium and other trace elements in spinal cord, liver and bone in motor neurone disease. Eur Neurol 1991; 31: 7-11.
23. Moos T. Age-dependent uptake and retrograde axonal transport of exogenous albumin and transferrin in rat motor neurons. Brain Res 1995; 672: 14-23.
24. MORISI G, PATRIARCA M, MENOTTI A. Improved determination of selenium in serum by Zeeman atomic absorption spectrometry. Clin Chem 1988; 34: 127-130.
25. MORIWAKA F, SATOH H, EJIMA Z, et al. Mercury and selenium contents in amyotrophic lateral sclerosis in Hokkaido, the northernmost island of Japan. J Neurol Sei 1993; 118: 38-42.
26. MURRAY TJ, CAMERON J, HEFFERMAN LP. et al. Amyotrophic lateral sclerosis in Nova Scotia. Adv Exp Med Biol 1987; 209: 345-349.
27. NEHRU B, IYER A. Effect of selenium on lead-induced neurotoxicity in different brain regions of adult rats. J Environ Pathol Toxicol Oncol 1994; 13: 265-268.
28. PANTER KE, HARTLEY WJ, JAMES LF, MAYLAND HF, STEGELMEIER EL, KECHELE PO. Comparative toxicity of selenium from seleno-DL-methionine, sodium selenate, and Astragalus bisulcatus in pigs. Fund Appl Toxicol 1996; 32: 217-223.
29. PiERCE-RUHLAND R, PATTERN BM. Repeat study of antecedent events in motor neuron disease. Ann Clin Res 1981; 13: 102-107.
30. SAVETTIERI G, SALEMI G, ARCARA A, CASSATA M, CASTIGLIONE MG, FIERRO B. A case-control study of amyotrophic lateral sclerosis. Neuroepidemiology 1991; 10: 242-245.
31. SHAW PJ, INCE PG, FALKOUS G, MANTLE D. Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann Neurol 1995; 38: 691-695.
32. SILLEVIS SMITT PAE, VAN BEEK H, BAARS A, et al. Increased metallothionein in the liver and kidney of patients with amyotrophic lateral sclerosis. Arch Neurol 1992; 49: 721-724.
33. SPALLHOLZ JE. On the nature of selenium toxicity and carcinostatic activity. Free Radical Biol Med 1994; 17: 45-64.
34. VINCETI M, GUIDETTI D, PiNOTTi M, et al. Amyotrophic lateral sclerosis after long-term exposure to drinking water with high selenium content. Epidemiology 1996; 7: 529-532.
35. VIVOLI G, BERGOMI M, BORELLA P, FANTUZZI G, CASELGRANDI E. Cadmium in blood, urine and hair related to human hypertension. J Trace Elem Electrolytes Health Dis 1989; 3: 139-145.
36. WILLIAMS DB, WINDEBANK AJ. Motor neuron disease (amyotrophic lateral sclerosis). Mayo Clin Proc 1991; 66: 54-82.
37. WILSON TM, SCHOLZ RW, DRAKE TR. Selenium toxicity and porcine focal symmetrical poliomyelomalacia: description of a field outbreak and experimental reproduction. Can J Comp Med 1983; 47: 412-421.